Anti-E Cadherin antibody [M168] - C-terminal
- BOND RX™ Validated
- Lab Essentials
- What is this?
4
(18 Reviews)
|
(482 Publications)
Anti-E Cadherin antibody [M168] - C-terminal (ab76055) is a mouse monoclonal antibody detecting E Cadherin in Western Blot, Flow Cytometry (Intra), IHC-P. Suitable for Human.
- Over 400 publications
- Trusted since 2009
View Alternative Names
CD324, Cadherin-1, ARC-1, Epithelial cadherin, Uvomorulin, E-cadherin, Cdh1
- WB
Supplier Data
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
Blocked and probed in the presence of 5% milk, and the image was captured using chemiluminescence and film.
Lane 1:
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (ab76055) at 1/1000 dilution
Lane 2:
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (ab76055) at 1/2000 dilution
Lane 3:
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (ab76055) at 1/4000 dilution
All lanes:
A431 (Human epidermoid carcinoma cell line) denatured whole cell lysate at 10 µg
Predicted band size: 97 kDa
false
Exposure time: 2min
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
Immunohistochemistry staining of E Cadherin in human MMCR (Muller's muscle conjunctival resection) tissue.
Xylene and rehydration with serial ethanol dilutions were used for deparaffinization. Slides were washed twice for 5 minutes in 0.25% Triton X-100 for permeabilization and blocked for 2 hours at room temperature with 2% BSA and 10% normal donkey serum in PBS. Slides were incubated overnight at 4°C with ab76055. The next day, the slides were washed twice for 5 minutes in PBS and incubated for 1–2 hours with respective secondary antibodies diluted in blocking solution (1 : 200–800). Vecta shield mounting medium with 4′,6-diamidino-2-phenylindole (DAPI) was placed over the slides and covered with a glass coverslip. Slides were analyzed using the Zeiss LSM 710 Confocal Microscope.
Shah et al PLoS One. 2016 Jan 29;11(1):e0148018. doi: 10.1371/journal.pone.0148018. eCollection 2016. Fig 2. Reproduced under the Creative Commons license https://creativecommons.org/publicdomain/zero/1.0/
- ICC
Lab
Immunocytochemistry - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
ICC/IF image of ab76055 stained A431 (Human epidermoid carcinoma cell line) cells.
The cells were 4% formaldehyde fixed (10 minutes) and then incubated in 1% BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1 hour to permeabilize the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab76055, 1/100 dilution) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1 hour. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1 hour. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43 μM.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
Overlay histogram showing A431 (Human epidermoid carcinoma cell line) cells stained with ab76055 (red line).
The cells were fixed with 4% paraformaldehyde (10 minutes) and then permeabilized with 0.1% PBS-Tween for 20 minutes. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab76055, 1/100 dilution) for 30 minutes at 22°C. The secondary antibody used was a DyLight® 488 goat anti-mouse IgG (H+L) ab96879 at 1/500 dilution for 30 minutes at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2 μg/1x106 cells) used under the same conditions.
Acquisition of >5,000 events was performed.
This antibody gave a positive signal in A431 cells fixed with 80% methanol (5 minutes)/permeabilized with 0.1% PBS-Tween for 20 minutes used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
IHC image of E Cadherin staining in human colon formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer pH 6, for 20 minutes. The section was then incubated with ab76055, 5 μg/ml, for 15 minutes at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- WB
CiteAb
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
Western Blotting using Anti-E Cadherin antibody [M168] - C-terminal, ab76055. Publication image from Redon, C. E. et al., 2016, Nat Commun, 26876487. Legend direct from paper.
Downregulation of the transcription factors Slug and ZEB1 reverses the EMT programme induced by H2A.X deficiency.(a) Control cells (shCTRL) and cells silenced for H2A.X (shH2A.X) were transfected for 3 days with control siRNA (siC) or with a pool of siSLUG and siZEB1 (siS/Z). Immunoblot analysis of EMT markers was performed using tubulin as loading control. (b) Staining of E-cadherin and β-catenin by immunofluorescence in HCT116 control cells (shCTRL) and H2A.X-deficient cells (shH2A.X) transfected for 3 days with control siRNA (siC) or a pool of siRNAs against SLUG and ZEB1 (siS/Z). Nuclei were counterstained with propidium iodide (red); scale bars, 20 µm. (c) Top panel, analysis of cell phenotypic changes through the staining of F-actin (phalloidin) by immunofluorescence using conditions described in b; scale bars, 20 µm. Bottom panel, photomicrographs of cells; scale bar, 100 µm.(d) Immunoblot analysis of EMT markers in HCT116 parental cells (WT) and H2A.X knockout cells (KO) transfected for 3 days with siRNA control (siC) or with a pool of siSLUG and siZEB1 (siS/Z) with tubulin-loading controls. H2A.X knockout cells were generated using CRISPR/Cas9 system for precise deletion of the H2A.X gene. cl.5, clone #5; and cl.6, clone #6. (e) Immunofluorescence assays showing E-cadherin and β-catenin staining. Cells were treated as in d. Nuclei were counterstained in red with propidium iodide; scale bars, 20 µm.
false
- WB
CiteAb
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
Western Blotting using Anti-E Cadherin antibody [M168] - C-terminal, ab76055. Publication image from Redon, C. E. et al., 2016, Nat Commun, 26876487. Legend direct from paper.
H2A.X re-expression inhibits EMT and promotes metastatic colonization in the lung.(a) Immunoblot analysis of EMT markers in HCT116 parental cells (WT), H2A.X knockout cells (KO) and H2A.X knockout cells in which H2A.X expression was restored (KO+H2A.X), utilizing actin as a loading control. (b) HCT116 parental cells (WT), H2A.X knockout cells (KO) and revertant cells (KO+H2A.X) were analysed for transcripts levels of EMT markers by real-time PCR. Expression values for E-cadherin (CDH1), ZEB1, Slug, Vimentin (VIM), integrin beta 4 (ITGB4) and versican (VCAN) were normalized to 18S RNA (gene/18S ratio). Error bars represent the s.e. (n=3). Statistical significance was determined by a two-tailed, unpaired Student's t-test. The experiments were repeated three times. (c). Immunostaining of the epithelial marker E-cadherin. Nuclei were counterstained in red with propidium iodide; scale bars, 20 µm. Photomicrographs of cells are shown (top panel); scale bar, 100 µm. (d) Tail vein injections of HCT116 parental cells (WT) and H2A.X knockout cells (KO) showed similar numbers of lung metastatic foci 4 weeks post injection. Ectopic expression of H2A.X (KO+H2A.X) resulted in a 2.5-fold increase in lung macroscopic metastases. (e) Representative haematoxylin- and eosin-stained lung sections from mice injected with HCT116 parental cells (WT), H2A.X knockout cells (KO) and H2A.X knockout cells in which H2A.X expression was restored (KO+H2A.X). Black arrows indicate some macroscopic lung nodules. Scale bars, 1 mm. Statistical significance was determined by a two-tailed, unpaired Student's t-test.
false
- WB
CiteAb
Western blot - Anti-E Cadherin antibody [M168] - C-terminal (AB76055)
Western Blotting using Anti-E Cadherin antibody [M168] - C-terminal, ab76055. Publication image from Redon, C. E. et al., 2016, Nat Commun, 26876487. Legend direct from paper.
Downregulation of the transcription factors Slug and ZEB1 reverses the EMT programme induced by H2A.X deficiency.(a) Control cells (shCTRL) and cells silenced for H2A.X (shH2A.X) were transfected for 3 days with control siRNA (siC) or with a pool of siSLUG and siZEB1 (siS/Z). Immunoblot analysis of EMT markers was performed using tubulin as loading control. (b) Staining of E-cadherin and β-catenin by immunofluorescence in HCT116 control cells (shCTRL) and H2A.X-deficient cells (shH2A.X) transfected for 3 days with control siRNA (siC) or a pool of siRNAs against SLUG and ZEB1 (siS/Z). Nuclei were counterstained with propidium iodide (red); scale bars, 20 µm. (c) Top panel, analysis of cell phenotypic changes through the staining of F-actin (phalloidin) by immunofluorescence using conditions described in b; scale bars, 20 µm. Bottom panel, photomicrographs of cells; scale bar, 100 µm.(d) Immunoblot analysis of EMT markers in HCT116 parental cells (WT) and H2A.X knockout cells (KO) transfected for 3 days with siRNA control (siC) or with a pool of siSLUG and siZEB1 (siS/Z) with tubulin-loading controls. H2A.X knockout cells were generated using CRISPR/Cas9 system for precise deletion of the H2A.X gene. cl.5, clone #5; and cl.6, clone #6. (e) Immunofluorescence assays showing E-cadherin and β-catenin staining. Cells were treated as in d. Nuclei were counterstained in red with propidium iodide; scale bars, 20 µm.
false
Reactivity data
Product details
Anti-E Cadherin antibody [M168] - C-terminal (ab76055) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples.
What is the molecular weight of E Cadherin?
Anti-E Cadherin [M168] - C-terminal (ab76055) specifically detects a band for E Cadherin (UniProt: P09803) at a molecular weight of 97kDa.
Trusted by the scientific community
Anti-E Cadherin [M168] - C-terminal (ab76055) was first used in a scientific publication in 2009 and has been cited over 400 times in peer-reviewed journals.
Reviewed by scientists
Anti-E Cadherin [M168] - C-terminal (ab76055) has over 15 independent reviews from customers.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
E-Cadherin participates in establishing and maintaining adherens junctions which are vital for tissue structure. E-Cadherin operates as a core component of the cadherin-catenin complex which links the protein to the actin cytoskeleton. Through this linkage E-Cadherin plays an important role in signaling pathways that influence cellular growth and differentiation. The protein's ability to mediate intercellular connections also regulates cellular motility and supports basic aspects of cell behavior in epithelial tissues.
Pathways
E-Cadherin influences both the Wnt signaling pathway and the epithelial-to-mesenchymal transition (EMT). Within the Wnt signaling pathway E-Cadherin partners with Β-catenin a significant player in transcription regulation and cell signaling. Disruption in E-Cadherin's adhesive functionality can lead to increased Β-catenin availability affecting downstream transcriptional control. In the EMT process E-Cadherin loss characterizes an important step in which cells gain migratory and invasive properties typically seen during metastasis in cancer progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (482)
Recent publications for all applications. Explore the full list and refine your search
Journal of inflammation research 18:13575-13592 PubMed41054626
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of surgical oncology 23:350 PubMed41024019
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:31927 PubMed40883446
2025
Applications
Unspecified application
Species
Unspecified reactive species
Hereditas 162:177 PubMed40883807
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 29:e70695 PubMed40839490
2025
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 15:7440-7453 PubMed40756363
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 15:1568367 PubMed40666104
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pediatric discovery.. 2:e94 PubMed40626133
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 11:241 PubMed40382334
2025
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 17:1679-1693 PubMed40225990
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com